Lu AF88434
/ Lundbeck
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
February 24, 2021
Study Investigating the Safety and Tolerability of Lu AF88434 in Healthy Young Men
(clinicaltrials.gov)
- P1; N=68; Completed; Sponsor: H. Lundbeck A/S; Recruiting ➔ Completed; Trial completion date: Mar 2020 ➔ Sep 2020; Trial primary completion date: Mar 2020 ➔ Sep 2020
Clinical • Trial completion • Trial completion date • Trial primary completion date
February 24, 2021
A Study in Healthy Men to Investigate Uptake and Distribution of Lu AF88434 in the Brain
(clinicaltrials.gov)
- P1; N=8; Completed; Sponsor: H. Lundbeck A/S; Recruiting ➔ Completed
Clinical • Trial completion
September 03, 2020
A Study in Healthy Men to Investigate Uptake and Distribution of Lu AF88434 in the Brain
(clinicaltrials.gov)
- P1; N=8; Recruiting; Sponsor: H. Lundbeck A/S
Clinical • New P1 trial
1 to 3
Of
3
Go to page
1